Clinical trial
Study of Trilaciclib and Lurbinectedin in Small Cell Lung Cancer
NCT05578326 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Trilaciclib and Lurbinectedin in Small Cell Lung Cancer
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- October 12, 2022
- Completion date
- December 25, 2028
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, small-cell lung cancer